Ai2 and Providence Swedish expand collaboration after AutoDiscovery finds breast cancer immune signal
#ai2#cancer research#auto discovery#collaboration
The Allen Institute for AI (Ai2) and Providence Swedish Cancer Institute are expanding their collaboration after Ai2's AutoDiscovery system helped researchers uncover and validate a new immune signal in invasive lobular breast cancer. The partnership aims to advance AI-assisted scientific discovery in cancer research.
Coverage timeline
Ai2 (Allen Institute for AI)
Ai2 and Providence Swedish Cancer Institute are expanding their collaboration after AutoDiscovery helped researchers uncover and validate a promising new immune signal in invasive lobular breast cancer.
